You diagnose the patient, pick the medication, send the prescription, and document the plan.
Beautiful. Efficient. Guideline-concordant.
Two months later, the patient is back. Blood sugar: still high.
"Were you able to start the medication?"
They pause.
"No. The pharmacy said it wasn't ready. Then it was too expensive. Then I wasn't sure if I really needed it."
The prescription was sent. The treatment plan was made. But the therapy never actually started.
That gap has a name: primary medication nonadherence, often called prescription abandonment. In plain English, it means the patient never starts the medication you prescribed.
Not “missed a few doses.” Not “stopped after three months.” Never started.
The medication may be sitting at the pharmacy, blocked by insurance, delayed by prior authorization, priced too high, or quietly abandoned because the patient was unsure what to do next.
A prescription is not clinically useful just because it was sent. It only becomes useful when the patient can actually start therapy.
Before We Call It "Nonadherence," Let's Talk About Access
Medication adherence is often framed as a patient behavior problem: Did the patient take it? Did they refill it? Did they follow instructions?
Those questions matter. But with prescription abandonment, we need to ask an earlier one:
Did the patient ever get a fair shot at starting it?
A 2025 state-of-the-science overview in Frontiers in Pharmacology describes medication adherence as a multidimensional issue shaped by patient, provider, treatment, and health system factors. Translation: adherence is not just about motivation. It is also about cost, communication, workflow, trust, logistics, and follow-up.
Which sounds about right if you have ever tried to get a patient started on a branded GLP-1, biologic, anticoagulant, or honestly, sometimes even a generic medication on a bad pharmacy day.
For patients with chronic conditions like hypertension, heart failure, diabetes, rheumatoid arthritis, psoriasis, asthma, depression, or hyperlipidemia, the stakes are not small. A medication cannot improve A1c, prevent flares, or reduce cardiovascular risk if it is sitting unfilled at the pharmacy.
Where Prescriptions Fall Apart
For clinicians, clicking "send" can feel like the end of the prescribing process. For patients, it is often the beginning of a maze. The prescription may travel electronically, but the patient still has to navigate a very real obstacle course:
- Is it covered?
- Is it affordable?
- Is it in stock?
- Does it require prior authorization?
- Did it go to the right pharmacy?
- Does the patient know why they are taking it?
- Does the patient know what to do if the pharmacy says, "We're waiting on your doctor"?
That last one is the unofficial soundtrack of outpatient medicine.
Cost is one of the biggest barriers. Even insured patients may run into high deductibles, copays, coinsurance, or confusing pharmacy benefit rules. A 2023 study in the Journal of Evaluation in Clinical Practice found cost-related medication nonadherence among Medicare beneficiaries with cardiovascular disease risk factors, including hypertension, hyperlipidemia, diabetes, and obesity.
In other words, affordability is not a rare edge case. It is a clinical issue.
Patients may also hesitate because they do not understand why the medication matters, worry about side effects, distrust long-term therapy, miss a pharmacy text, or get stuck in prior authorization limbo.
The result is a familiar disconnect: the clinician thinks treatment has started, the patient thinks, "I guess I'll wait," and the pharmacy is still waiting on more information. Meanwhile, the disease process keeps doing what disease processes do.
Rude, honestly.
Why Pharmacists Are Central to the Solution
Pharmacists often see the thing clinicians do not: the moment the treatment plan collides with real life.
They see the copay, the rejection, the medication that was never picked up, and the patient who says, "I'm not sure what this is for."
A 2023 study in the Journal of the American Pharmacists Association evaluated a pharmacist-led primary medication nonadherence intervention program in underserved patient populations and found that pharmacist outreach can support improved prescription fill behavior.
That makes sense. Pharmacists are positioned at the access point. They can help identify whether the barrier is cost, confusion, coverage, inventory, counseling, or follow-up. Those are very different problems. A patient afraid of side effects needs counseling. A patient facing a $400 copay needs an affordability pathway. A patient stuck in prior authorization needs workflow support. A patient whose prescription went to the wrong pharmacy needs logistics fixed. A patient who does not understand why they need the medication needs the treatment plan translated into plain language.
This is where pharmacists can help turn a sent prescription into a started therapy.
A 30-Second Access Check Before You Click Send
No one needs another 17-step checklist during a busy clinic day. But a few targeted questions can prevent a lot of abandoned prescriptions:
- "Which pharmacy do you actually use?"
- "Do you ever have trouble affording medications?"
- "Have you had insurance issues with medications before?"
- "Do you know why we are starting this?"
- "What will you do if the pharmacy says it is delayed or not covered?"
That last question is sneaky useful. Because if the patient says, "I guess I'll just wait," you have found the gap.
Give them a next step before they leave:
"If the pharmacy says it is not ready, too expensive, or needs approval, call us or message us. Do not just walk away from it. We can usually troubleshoot."
That is a small sentence with a big job.
The Bottom Line
The most elegant treatment plan in the world is useless if the patient cannot start it.
Prescription abandonment is not just about patient motivation. It is about access, affordability, counseling, pharmacy workflows, insurance barriers, follow-up, and visibility.
Before we label someone "nonadherent," we should ask whether the system made adherence harder than it needed to be.
Clinicians do not need to solve every medication access problem alone. Pharmacists, care teams, digital tools, and better prescription-status visibility can help close the gap between prescribing a medication and a patient actually starting it.
Because the goal is not just to send the prescription. The goal is to help patients move from prescription to treatment.
References
Crawshaw J, McCleary N. Healthcare provider interventions to support medication adherence: state-of-the-science overview. Frontiers in Pharmacology. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12322503/
Choudhry NK, et al. Impact of a pharmacist-led, primary medication nonadherence intervention program on prescription fills in underserved patient populations. Journal of the American Pharmacists Association. 2023. https://pubmed.ncbi.nlm.nih.gov/37024012/
Qato DM, et al. Cost-related medication nonadherence among Medicare beneficiaries with cardiovascular disease risk factors. Journal of Evaluation in Clinical Practice. 2023;29(1):136-145. https://pubmed.ncbi.nlm.nih.gov/35982538/
